These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27638496)

  • 1. Anti-inflammatory effect of prophylactic macrolides on children with chronic lung disease: a protocol for a double-blinded randomised controlled trial.
    Mosquera RA; Gomez-Rubio AM; Harris T; Yadav A; McBeth K; Gonzales T; Jon C; Stark J; Avritscher E; Pedroza C; Smith K; Colasurdo G; Wootton S; Piedra P; Tyson JE; Samuels C
    BMJ Open; 2016 Sep; 6(9):e012060. PubMed ID: 27638496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.
    Gonzalez-Martinez C; Kranzer K; McHugh G; Corbett EL; Mujuru H; Nicol MP; Rowland-Jones S; Rehman AM; Gutteberg TJ; Flaegstad T; Odland JO; Ferrand RA;
    Trials; 2017 Dec; 18(1):622. PubMed ID: 29282143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants.
    Lowe J; Gillespie D; Hubbard M; Zhang L; Kirby N; Pickles T; Thomas-Jones E; Turner MA; Klein N; Marchesi JR; Hood K; Berrington J; Kotecha S
    BMJ Open; 2020 Oct; 10(10):e041528. PubMed ID: 33028566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial).
    Pavlinac PB; Singa BO; John-Stewart GC; Richardson BA; Brander RL; McGrath CJ; Tickell KD; Amondi M; Rwigi D; Babigumira JB; Kariuki S; Nduati R; Walson JL
    BMJ Open; 2017 Dec; 7(12):e019170. PubMed ID: 29289941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
    Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
    Trials; 2012 Jun; 13():82. PubMed ID: 22682323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.
    Kobbernagel HE; Buchvald FF; Haarman EG; Casaulta C; Collins SA; Hogg C; Kuehni CE; Lucas JS; Omran H; Quittner AL; Werner C; Nielsen KG
    BMC Pulm Med; 2016 Jul; 16(1):104. PubMed ID: 27450411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
    Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
    Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial.
    Mandhane PJ; Paredes Zambrano de Silbernagel P; Aung YN; Williamson J; Lee BE; Spier S; Noseworthy M; Craig WR; Johnson DW
    PLoS One; 2017; 12(8):e0182411. PubMed ID: 28771627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.
    Chang AB; Grimwood K; White AV; Maclennan C; Sloots TP; Sive A; McCallum GB; Mackay IM; Morris PS
    Trials; 2011 Apr; 12():94. PubMed ID: 21492416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
    Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M; Schneer S; Lavon O; Adir Y
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial.
    Kneyber MC; van Woensel JB; Uijtendaal E; Uiterwaal CS; Kimpen JL;
    Pediatr Pulmonol; 2008 Feb; 43(2):142-9. PubMed ID: 18085694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.
    Sie A; Bountogo M; Nebie E; Ouattara M; Coulibaly B; Bagagnan C; Zabre P; Lebas E; Brogdon J; Godwin WW; Lin Y; Porco T; Doan T; Lietman TM; Oldenburg CE;
    BMJ Open; 2019 Sep; 9(9):e031162. PubMed ID: 31488494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
    Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
    Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.
    Clement A; Tamalet A; Leroux E; Ravilly S; Fauroux B; Jais JP
    Thorax; 2006 Oct; 61(10):895-902. PubMed ID: 16809416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.